Monday, March 10, 2025 | 08:35 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Page 13 - Bharat Biotech

Bharat Biotech may begin Covaxin trial for 2-18 age group in June

Bharat Biotech may begin paediatric trials of its Covid-19 vaccine Covaxin from June, said the company's Business Development and International Advocacy Head Dr Raches Ella on Sunday.

Bharat Biotech may begin Covaxin trial for 2-18 age group in June
Updated On : 24 May 2021 | 6:45 AM IST

No consensus yet on Covid vaccine passport issue at WHO level: Govt

'As of now, as per WHO guidelines and guidelines by other countries, people with negative COVID test report are being allowed,' says Health Ministry Joint Secretary

No consensus yet on Covid vaccine passport issue at WHO level: Govt
Updated On : 22 May 2021 | 11:18 PM IST

Bharat Biotech may receive Covaxin drug substance from IIL in June

The Union health ministry said recently that it expects 750 million doses of Covishield to be available between August and December.

Bharat Biotech may receive Covaxin drug substance from IIL in June
Updated On : 22 May 2021 | 6:10 AM IST

India is world's vaccine factory: What happens when it can't deliver

India stopped exporting Covid-19 vaccines in mid-April, leaving low-income and lower-middle-income countries in the lurch.

India is world's vaccine factory: What happens when it can't deliver
Updated On : 21 May 2021 | 12:25 PM IST

Bharat Biotech adds 200 million dose per annum Covaxin capacity

The company said the quick ramp up of additional manufacturing capacities for Covaxin was done at Chiron Behring Vaccines, Ankleshwar Gujarat, a wholly owned subsidiary of Bharat Biotech

Bharat Biotech adds 200 million dose per annum Covaxin capacity
Updated On : 21 May 2021 | 12:31 AM IST

Bharat Biotech to ramp up Covaxin production, make 200 mn doses a year

'Product availability of additional doses to commence from Q4, 2021 at Chiron Behring Vaccines Ltd, located in Ankleshwar, Gujarat,' Bharat Biotech says

Bharat Biotech to ramp up Covaxin production, make 200 mn doses a year
Updated On : 20 May 2021 | 9:08 PM IST

SII, Bharat Biotech to get bulk of Rs 15K-crore profit pool: Report

At present, SII sells its vaccine Covishield to the Centre for Rs 150 per dose, to state governments for Rs 300 and to private hospitals for Rs 600.

SII, Bharat Biotech to get bulk of Rs 15K-crore profit pool: Report
Updated On : 20 May 2021 | 6:10 AM IST

No diversion, Bharat Biotech Pune plant as per Bombay HC order: Ajit Pawar

Maharashtra Deputy Chief Minister Ajit Pawar on Monday dismissed the allegation that he has diverted a Bharat Biotech project of manufacturing Covid-19 vaccines to his home district Pune

No diversion, Bharat Biotech Pune plant as per Bombay HC order: Ajit Pawar
Updated On : 18 May 2021 | 7:50 AM IST

'Karnataka facility can produce 40-50 mn Covaxin doses a month by Aug-end'

Bharat Biotech's Covaxin manufacturing facility that is under construction in Karnataka would have a manufacturing capacity of 40 to 50 million doses a month by August-end, says state Health Minister

'Karnataka facility can produce 40-50 mn Covaxin doses a month by Aug-end'
Updated On : 17 May 2021 | 4:16 PM IST

The way forward for firms

Indian firms need to prepare for export boom by vaccinating employees, their family members; and prioritise export market

The way forward for firms
Updated On : 17 May 2021 | 12:49 PM IST

Hester Biosciences zooms 33% in 2 days as firm in talks to produce Covaxin

The company said it has tied up with the Gujarat government to explore the production of Covid-19 vaccine through technology transfer from Bharat Biotech

Hester Biosciences zooms 33% in 2 days as firm in talks to produce Covaxin
Updated On : 17 May 2021 | 9:55 AM IST

Covaxin capacity scaled up to 500 million doses a year: Bharat Biotech

Vaccine effective against all emerging coronavirus variants, says study

Covaxin capacity scaled up to 500 million doses a year: Bharat Biotech
Updated On : 17 May 2021 | 2:25 AM IST

Hester in talks with Bharat Biotech to produce Covaxin via tech transfer

Hester Biosciences on Sunday said it has tied up with the Gujarat government to explore the production of the Covid-19 vaccine through technology transfer from Bharat Biotech

Hester in talks with Bharat Biotech to produce Covaxin via tech transfer
Updated On : 17 May 2021 | 12:03 AM IST

The vaccine gap

Timelines suggest govt must focus on health infra too

The vaccine gap
Updated On : 16 May 2021 | 10:54 PM IST

Covaxin effective against India, UK coronavirus strains: Bharat Biotech

Bharat Biotech said its Covid-19 vaccine 'Covaxin' has been found to be effective against coronavirus strains found in India and the UK

Covaxin effective against India, UK coronavirus strains: Bharat Biotech
Updated On : 16 May 2021 | 4:38 PM IST

Bharat Biotech setting up Covaxin-manufacturing unit in K'taka: Deputy CM

Karnataka will soon have a Covaxin-manufacturing plant of Bharat Biotech in Kolar district near, says Deputy Chief Minister of the State Dr C N Ashwath Narayan

Bharat Biotech setting up Covaxin-manufacturing unit in K'taka: Deputy CM
Updated On : 14 May 2021 | 8:29 PM IST

Bharat Biotech dispatches Covaxin to various states like Gujarat, Assam

Bharat Biotech on Friday said it has dispatched COVID vaccine Covaxin to various states like Gujarat, Assam, Tamil Nadu, Karnataka and Odisha. The Hyderabad-based vaccine major, which has come under fire from the Delhi government over supply-related issues, said it has also dispatched Covaxin lots to Kerala and Uttarakhand. "Covaxin goes to Gandhinagar, Guwahati, Chennai, Hyderabad, Bengaluru & Bhuvneshwar. thank all our employees @ BHarat bio who worked thru the holy month of Ramzan..." Bharat Biotech Co-Founder and Joint Managing Director Suchitra Ella said in a tweet. Earlier in a late night tweet on Thursday, she tweeted informing supply of the much in demand vaccine to Kerala and Uttarakhand. "Covaxin sent to Kerala & Uttarakhand. Thanq for the concern, many offered to help. Our work is highly stringent, realtime & technical,no work from home! All Our employees will be taken care of, won't deter us from our mission! Let's be thankful,helpful & hopeful always," she

Bharat Biotech dispatches Covaxin to various states like Gujarat, Assam
Updated On : 14 May 2021 | 1:10 PM IST

Bharat Biotech unit to make Pune plant functional for vax production by Aug

Biovet Pvt Ltd, an associate firm of Bharat Biotech, is confident of making a plant at Manjari in Pune fully functional for vaccine production by August-end, a senior administrative official said

Bharat Biotech unit to make Pune plant functional for vax production by Aug
Updated On : 14 May 2021 | 10:53 AM IST

India's vaccine supplies to improve as it braces for Covid-19 third wave

India has vaccinated 37.2 million people with both doses of a vaccine, and about 135.5 million have received at least the first jab

India's vaccine supplies to improve as it braces for Covid-19 third wave
Updated On : 14 May 2021 | 8:59 AM IST

Fifty employees of Bharat Biotech test Covid-19 positive: Joint MD Ella

The firm is supplying Covaxin to 18 states, including AP, Haryana, Odisha, Assam, J&K, Tamil Nadu, Bihar, Jharkhand as well as Delhi

Fifty employees of Bharat Biotech test Covid-19 positive: Joint MD Ella
Updated On : 14 May 2021 | 12:10 AM IST